Evidence map›Paper›PMID 42352914›Full record

ArticleInternational journal of molecular sciences2026

Diffusion-Controlled Drug Release from Electrospun Poly(3-hydroxybutyrate) Fibers with Beaded Architecture: An Experimental and Modeling Study.

Alexey Iordanskii, Pavel Borovikov, Valentina Siracusa, Anatoliy Olkhov, Polina Tyubaeva, Sergey Frolov, Alexander Berlin

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexey IordanskiiSemenov Federal Research Center for Chemical Physics Academy of Science, Kosygina St. 4, 119991 Moscow, Russia.ORCID 0000-0003-0771-0825
Pavel BorovikovNational Medical Research Center for Obstetrics, Gynecology and Perinatology Named After Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, 117997 Moscow, Russia.ORCID 0000-0003-4880-7500
Valentina SiracusaDepartment Chemical Science (DSC), University of Catania, Viale A. Doria 6, 95125 Catania, Italy.ORCID 0000-0001-9055-5082
Anatoliy OlkhovSemenov Federal Research Center for Chemical Physics Academy of Science, Kosygina St. 4, 119991 Moscow, Russia.ORCID 0000-0003-0615-6914
Polina TyubaevaAcademic Department of Technology and Chemistry of Innovative Materials, Plekhanov University of Economics, Stremyanny Per. 36, 117997 Moscow, Russia.ORCID 0000-0003-4217-2022
Sergey FrolovSemenov Federal Research Center for Chemical Physics Academy of Science, Kosygina St. 4, 119991 Moscow, Russia.ORCID 0000-0002-5555-1876
Alexander BerlinSemenov Federal Research Center for Chemical Physics Academy of Science, Kosygina St. 4, 119991 Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The global transition from petrochemical to sustainable bio-based plastics has been strongly supported by electrospinning (ES), a versatile nanotechnology enabling the fabrication of ultrathin fibers with multifunctional properties. The solution ES process alongside the uniform fibers, a characteristic "beads-on-string" morphology, consisting of alternating cylindrical and spindle-like segments, is frequently observed. Once considered undesirable, these structures are now recognized as functional fibrous architectures with enhanced properties. This work explores the valorization of beaded fibers through combined experimental characterization and modeling, aiming to evaluate the impact of beading on drug diffusion and delivery performance. Poly(3-hydroxybutyrate) (PHB) was selected as the model biopolyester and dipyridamole (DPD) as the model drug. Ultrathin fibers were fabricated using the laboratory electrospinning device, EFV-1 (ICP, Moscow, Russia). The distance between the capillary nozzle and the anodic collector was set to 180 mm, with the capillary tip radius equal to 0.35 mm, and applied voltage between the electrodes was kept constant at 18 kV. Drug release profiles were obtained by simulating DPD diffusion in ellipsoidal (beads) and cylindrical fiber domains. Ultrathin fibers were fabricated by solution electrospinning under environmental conditions (at ambient temperature, 50% relative humidity). Morphology was analyzed via SEM, thermal properties via DSC, and structure via FTIR spectroscopy at different temperatures, including the melting point (~170 °C). Drug release kinetics were monitored using a UV-Vis spectroscopy. The impact of DPD diffusion within the ellipsoidal and cylindrical constituents of polymer filaments was considered to modulate release profiles for the development of innovative pharmaceutical platforms. Diffusion controlled drug release was computationally modeled using a specially designed simulation program, in good agreement with experimental data. The results demonstrate that morphological parameters significantly affect diffusion and release kinetics. The controlled exploitation of bead-on-string architectures may enable the design of electrospun materials with tunable absorption of pollutant filtration, mechanical performance, and flexibility in drug release profiles, for sustainable biopolymers like PHB.

Indexed as

Drug LiberationPolyhydroxybutyratesDelayed-Action PreparationsDiffusionKineticsNanofibersSpectroscopy, Fourier Transform InfraredDelayed-Action PreparationsPolyhydroxybutyratesbeads-on-string morphologybiodegradable polymersdiffusion-controlled releasedrug deliveryelectrospinningelectrospun fibersfiber morphologymathematical modelingpoly(3-hydroxybutyrate) (PHB)

Identifiers

PMID42352914
PMCPMC13299927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.